VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

SABCS 2020 | Hot topics at SABCS 2020

Sangeetha Reddy, MD, UT Southwestern Medical Center, Dallas, TX, discusses practice-changing data presented at SABCS 2020 including results from the RxPONDER study (NCT01272037), Phase III trial evaluating whether the Oncotype DX® test can be used to spare chemotherapy in women with node-positive early-stage breast cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter